Celerion And Korean Drug Development Fund Form Collaboration To Strengthen Early Phase Clinical Research In South Korea
5/28/2014 10:04:51 AM
LINCOLN, Neb. & SEOUL, South Korea--(BUSINESS WIRE)--Celerion and the Korean Drug Development Fund (KDDF) are pleased to announce their formal collaboration to provide drug development expertise and support for the emerging drug discovery and development industry in South Korea.
The agreement in the form of a Memorandum of Understanding (MOU) provides the framework for collaborations of mutual benefit to both organizations. Companies funded by KDDF will have access to Celerion’s extensive experience and expertise in early clinical research and bioanalysis, as well as the global footprint of external partner sites. The collaboration will support a sharing of knowledge between KDDF and Celerion, and will focus on developing innovative and efficient ways to bring Korean drug discoveries to the global market. The MOU further enhances both organizations’ ability to effectively apply principles of translational medicine to the development of innovative new drugs.
Help employers find you! Check out all the jobs and post your resume.
comments powered by